Ashwin Ashok, MD
Gastroenterology · Whittier
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 21 years
- Graduated 2005
Offices
6 locations · Pih Health Physicians · 616 clinicians in this group
Hospitals listed: Pih Health Hospital-Whittier. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ashok’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A97611 · Current
Licensed to practise in California · since 2006 · expires 2028-06-30 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$95,497
Medicare paid this office $95,497 for 370 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 140 | $20,448 | $101 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 60 | $13,283 | $218 |
| New patient visit (45+ min) | 69 | $8,731 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,352 | $108 |
| Biopsy of large bowel using a flexible endoscope | 65 | $5,992 | $91 |
See all 14 services
| Return visit (30+ min) | 140 | $20,448 | $101 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 60 | $13,283 | $218 |
| New patient visit (45+ min) | 69 | $8,731 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $6,352 | $108 |
| Biopsy of large bowel using a flexible endoscope | 65 | $5,992 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $5,730 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | $4,530 | $85 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,874 | $94 |
| Long return visit (40+ min) | 11 | $1,779 | $148 |
| Short return visit (20+ min) | 19 | $1,448 | $66 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,413 | $74 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $403 | $22 |
| Measurement of liver stiffness | 14 | $387 | $28 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 12 | $249 | $19 |
Procedures Medicare counted
| Colonoscopy | 71 | More than 71% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 142 | More than 84% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of large bowel using a flexible endoscope | 51 | 60 | 64 | 71 | 50 | 66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 55 | 55 | 61 | 74 | 37 | 53 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | 36 | 32 | 41 | 39 | 61 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | 28 | 41 | 38 | 13 | 20 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | 12 | 15 | 31 | – | – |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | 13 | 15 | 14 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
370 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 12% · Women 55% · Also on Medicaid 34% · Health risk score 2.09. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 35% · Coronary heart disease 25% · Heart failure 23% · Atrial fibrillation 20% · Cancer 17% · Depression 17% · COPD 15% · Stroke 11% · Dementia 9%.
The office billed $564,699, Medicare allowed $122,299 and paid $95,497; for 857 services of 55 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 370 | 857 | 73 | 2.09 | $564,699 | $95,497 |
| 2023 | 314 | 708 | 73 | 2.28 | $456,673 | $79,553 |
| 2022 | 419 | 1,029 | 74 | 1.99 | $623,141 | $113,330 |
| 2021 | 372 | 944 | 73 | 2.12 | $544,184 | $108,524 |
| 2020 | 338 | 850 | 72 | 2.71 | $500,410 | $87,794 |
| 2019 | 425 | 1,100 | 73 | 2.82 | $609,054 | $112,367 |
| 2018 | 396 | 1,006 | 72 | 2.71 | $526,793 | $101,455 |
| 2017 | 301 | 854 | 74 | 2.29 | $458,676 | $85,100 |
| 2016 | 295 | 893 | 74 | 2.34 | $379,702 | $87,884 |
| 2015 | 272 | 950 | 74 | 2.48 | $345,118 | $92,154 |
| 2014 | 273 | 2,333 | 73 | 2.21 | $307,511 | $88,007 |
| 2013 | 155 | 432 | 69 | 2.15 | $148,712 | $41,646 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 137 | $20,368 | $100 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $8,804 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $6,163 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,500 | $108 |
| New patient visit (45+ min) | 43 | $5,324 | $124 |
| Biopsy of large bowel using a flexible endoscope | 50 | $4,494 | $90 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 13 | $2,980 | $199 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $2,850 | $77 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,360 | $105 |
| Short return visit (20+ min) | 14 | $1,200 | $80 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 11 | $218 | $20 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $156 | $14 |
2022: 13 services
| Return visit (30+ min) | 145 | $21,643 | $106 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 100 | $11,593 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $10,182 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $8,678 | $212 |
| New patient visit (45+ min) | 65 | $8,399 | $129 |
| Biopsy of large bowel using a flexible endoscope | 70 | $8,002 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $5,950 | $80 |
| Diagnostic exam of large bowel using a flexible endoscope | 30 | $4,458 | $144 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $3,295 | $87 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $2,726 | $195 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,295 | $191 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,187 | $35 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $165 | $14 |
2021: 14 services
| Return visit (30+ min) | 123 | $19,798 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 93 | $11,619 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $9,736 | $62 |
| New patient visit (45+ min) | 62 | $8,389 | $135 |
| Biopsy of large bowel using a flexible endoscope | 63 | $7,192 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 31 | $6,452 | $202 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $5,356 | $88 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $4,249 | $104 |
| Short return visit (20+ min) | 39 | $3,235 | $77 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $3,213 | $214 |
| Insertion of stomach tube using a flexible endoscope | 14 | $2,438 | $174 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,308 | $154 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,281 | $190 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,929 | $175 |
2020: 15 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 85 | $10,602 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $9,191 | $63 |
| Return visit (30+ min) | 77 | $8,659 | $90 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 35 | $8,057 | $224 |
| Biopsy of large bowel using a flexible endoscope | 59 | $5,472 | $91 |
| New patient visit (45+ min) | 35 | $4,692 | $134 |
| Short return visit (20+ min) | 60 | $4,109 | $56 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | $3,522 | $64 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $2,828 | $218 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,752 | $98 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $2,361 | $62 |
| Insertion of stomach tube using a flexible endoscope | 11 | $1,807 | $164 |
| New patient visit (30+ min) | 23 | $1,805 | $78 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,410 | $118 |
| Short return visit | 13 | $439 | $34 |
2019: 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 129 | $18,406 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 138 | $17,722 | $117 |
| Return visit (30+ min) | 92 | $10,347 | $89 |
| New patient visit (45+ min) | 55 | $7,237 | $132 |
| Biopsy of large bowel using a flexible endoscope | 51 | $6,986 | $137 |
| Short return visit (20+ min) | 73 | $5,532 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,452 | $218 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $4,200 | $76 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $3,721 | $207 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $2,930 | $92 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,578 | $172 |
| Insertion of stomach tube using a flexible endoscope | 14 | $2,375 | $170 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,223 | $202 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,893 | $158 |
| New patient visit (30+ min) | 22 | $1,788 | $81 |
2018: 14 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 136 | $16,474 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $14,925 | $62 |
| Return visit (30+ min) | 70 | $8,935 | $89 |
| New patient visit (45+ min) | 62 | $7,360 | $119 |
| Biopsy of large bowel using a flexible endoscope | 53 | $7,326 | $138 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 26 | $5,805 | $223 |
| Short return visit (20+ min) | 73 | $5,131 | $57 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $3,687 | $80 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $2,922 | $91 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,742 | $171 |
| New patient visit (30+ min) | 25 | $1,981 | $79 |
| Insertion of stomach tube using a flexible endoscope | 11 | $1,910 | $174 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,788 | $138 |
| Short return visit | 14 | $544 | $39 |
2017: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $9,398 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 68 | $8,828 | $116 |
| Short return visit (20+ min) | 108 | $8,540 | $57 |
| Return visit (30+ min) | 67 | $7,582 | $90 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 28 | $5,584 | $199 |
| Biopsy of large bowel using a flexible endoscope | 53 | $5,037 | $95 |
| New patient visit (30+ min) | 55 | $4,516 | $82 |
| New patient visit (45+ min) | 31 | $4,229 | $136 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 47 | $3,536 | $75 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,660 | $92 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,114 | $141 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,020 | $168 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $569 | $47 |
2016: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $11,892 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 86 | $10,707 | $115 |
| Short return visit (20+ min) | 110 | $10,648 | $60 |
| Removal of large bowel tissue using a flexible endoscope | 18 | $5,641 | $297 |
| New patient visit (30+ min) | 61 | $5,142 | $84 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 26 | $4,186 | $155 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $4,001 | $74 |
| Return visit (30+ min) | 33 | $3,304 | $92 |
| Biopsy of large bowel using a flexible endoscope | 33 | $3,155 | $96 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $3,049 | $235 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $2,205 | $100 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,096 | $191 |
| New patient visit (45+ min) | 13 | $1,784 | $137 |
2015: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $15,319 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 101 | $12,911 | $114 |
| Short return visit (20+ min) | 98 | $9,083 | $58 |
| Return visit (30+ min) | 45 | $6,223 | $88 |
| Biopsy of large bowel using a flexible endoscope | 33 | $5,020 | $143 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $4,702 | $261 |
| New patient visit (30+ min) | 52 | $4,136 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $3,913 | $85 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,340 | $98 |
| New patient visit (45+ min) | 14 | $1,969 | $141 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,896 | $172 |
2014: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $17,232 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 113 | $14,001 | $114 |
| Return visit (30+ min) | 62 | $7,792 | $81 |
| Biopsy of large bowel using a flexible endoscope | 34 | $6,347 | $187 |
| Short return visit (20+ min) | 54 | $4,779 | $62 |
| New patient visit (45+ min) | 36 | $4,629 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 43 | $4,417 | $100 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $3,224 | $170 |
| New patient visit (30+ min) | 29 | $2,581 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,316 | $101 |
2013: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $6,384 | $58 |
| New patient visit (45+ min) | 42 | $5,689 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,759 | $111 |
| Return visit (30+ min) | 31 | $3,351 | $88 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,071 | $173 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $2,008 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,965 | $109 |
| Short return visit (20+ min) | 12 | $1,052 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,036 | $31 |
| Short return visit (20+ min) | 15 | $718 | $38 |
Drugs they prescribed that Part D paid
$417,627
Pharmacies billed $417,627 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,766 generic and fewer than 11 brand-name prescriptions · $417,627 in drug cost · 85 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 111 | $141,749 | $1,277 |
| Linzess | 105 | $72,754 | $693 |
| Xifaxan | 14 | $38,240 | $2,731 |
| Mesalamine | 61 | $25,384 | $416 |
| Motegrity | 22 | $20,328 | $924 |
See all 36 drugs
| Creon | 111 | $141,749 | $1,277 |
| Linzess | 105 | $72,754 | $693 |
| Xifaxan | 14 | $38,240 | $2,731 |
| Mesalamine | 61 | $25,384 | $416 |
| Motegrity | 22 | $20,328 | $924 |
| Ursodiol | 50 | $14,315 | $286 |
| Trulance | 20 | $13,836 | $692 |
| Cholestyramine | 70 | $7,955 | $114 |
| Movantik | 18 | $7,197 | $400 |
| Omeprazole | 440 | $6,707 | $15 |
| Sod Sulf-Potass Sulf-Mag Sulf | 88 | $5,067 | $58 |
| Mesalamine Er | 15 | $4,860 | $324 |
| Pantoprazole | 308 | $4,578 | $15 |
| Lactulose | 40 | $3,932 | $98 |
| Lansoprazole | 88 | $3,692 | $42 |
| Sucralfate | 19 | $1,774 | $93 |
| Esomeprazole Magnesium | 27 | $1,020 | $38 |
| Cholestyramine Light | 12 | $1,000 | $83 |
| Gavilyte-C | 56 | $916 | $16 |
| Gavilyte-G | 62 | $823 | $13 |
| Colestipol | 13 | $822 | $63 |
| Constulose | 12 | $803 | $67 |
| Spironolactone | 47 | $793 | $17 |
| Rabeprazole | 22 | $710 | $32 |
| Famotidine | 48 | $639 | $13 |
| Azathioprine | 11 | $484 | $44 |
| Clarithromycin | 13 | $444 | $34 |
| Loperamide | 19 | $228 | $12 |
| Furosemide | 53 | $210 | $4 |
| Peg-3350 and Electrolytes | 13 | $209 | $16 |
| Propranolol | 13 | $99 | $8 |
| Diphenoxylate-Atropine | 12 | $82 | $7 |
| Amoxicillin | 14 | $48 | $3 |
| Metoclopramide | 18 | $45 | $3 |
| Levofloxacin | 23 | $39 | $2 |
| Lorazepam | 11 | $6 | $1 |
Year by year
| 2024 | 2,130 | 652 | None | None | $417,627 |
| 2023 | 1,886 | 626 | None | 15% | $573,333 |
| 2022 | 1,971 | 615 | 0% (0) | None | $516,519 |
| 2021 | 1,792 | 518 | None | None | $321,503 |
| 2020 | 1,780 | 563 | None | 15% | $215,793 |
| 2019 | 1,893 | 696 | None | 25% | $587,611 |
| 2018 | 1,939 | 615 | None | 23% | $584,478 |
| 2017 | 1,976 | 519 | None | 29% | $931,827 |
| 2016 | 1,762 | 460 | None | 25% | $875,775 |
| 2015 | 1,633 | 416 | None | 27% | $857,049 |
| 2014 | 1,137 | 306 | 0% (0) | 33% | $442,790 |
| 2013 | 304 | 104 | None | 30% | $35,794 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Creon | 93 | $117,046 | $1,259 |
| Xifaxan | 20 | $60,235 | $3,012 |
| Linzess | 34 | $33,074 | $973 |
| Mesalamine | 36 | $29,199 | $811 |
| Mesalamine Er | 21 | $14,658 | $698 |
| Cholestyramine | 72 | $12,522 | $174 |
| Ursodiol | 37 | $8,427 | $228 |
| Lansoprazole | 85 | $7,751 | $91 |
| Pantoprazole | 352 | $7,321 | $21 |
| Omeprazole | 337 | $6,962 | $21 |
| Trulance | 11 | $5,978 | $543 |
| Lactulose | 39 | $5,542 | $142 |
| Movantik | 13 | $5,530 | $425 |
| Lubiprostone | 16 | $4,628 | $289 |
| Sod Sulf-Potass Sulf-Mag Sulf | 55 | $3,694 | $67 |
| Sucralfate | 18 | $3,128 | $174 |
| Esomeprazole Magnesium | 12 | $1,924 | $160 |
| Gavilyte-G | 106 | $1,849 | $17 |
| Rabeprazole | 40 | $1,794 | $45 |
| Famotidine | 69 | $1,568 | $23 |
| Spironolactone | 38 | $954 | $25 |
| Mirtazapine | 16 | $712 | $45 |
| Azathioprine | 11 | $679 | $62 |
| Colestipol | 12 | $518 | $43 |
| Gavilyte-C | 24 | $377 | $16 |
| Peg-3350 and Electrolytes | 11 | $202 | $18 |
| Diphenoxylate-Atropine | 13 | $192 | $15 |
| Prednisone | 12 | $183 | $15 |
| Furosemide | 33 | $149 | $5 |
| Amoxicillin | 17 | $139 | $8 |
| Metronidazole | 13 | $124 | $10 |
| Propranolol | 12 | $92 | $8 |
| Metoclopramide | 24 | $77 | $3 |
| Levofloxacin | 24 | $48 | $2 |
2022: 32 drugs
| Creon | 92 | $107,700 | $1,171 |
| Xifaxan | 29 | $87,052 | $3,002 |
| Linzess | 66 | $47,299 | $717 |
| Mesalamine | 16 | $11,813 | $738 |
| Cholestyramine | 53 | $10,472 | $198 |
| Pantoprazole | 411 | $7,754 | $19 |
| Omeprazole | 415 | $7,675 | $18 |
| Lansoprazole | 89 | $5,774 | $65 |
| Tenofovir Disoproxil | 12 | $5,755 | $480 |
| Lactulose | 40 | $5,749 | $144 |
| Suprep | 43 | $4,889 | $114 |
| Ursodiol | 14 | $4,267 | $305 |
| Constulose | 17 | $1,650 | $97 |
| Famotidine | 59 | $1,164 | $20 |
| Sulfasalazine Dr | 17 | $1,111 | $65 |
| Spironolactone | 48 | $1,090 | $23 |
| Gavilyte-G | 69 | $1,032 | $15 |
| Prevalite | 11 | $1,019 | $93 |
| Sod Sulf-Potass Sulf-Mag Sulf | 13 | $993 | $76 |
| Rabeprazole | 29 | $802 | $28 |
| Peg 3350-Electrolyte | 23 | $497 | $22 |
| Peg-3350 and Electrolytes | 27 | $432 | $16 |
| Clarithromycin | 13 | $399 | $31 |
| Diphenoxylate-Atropine | 11 | $391 | $36 |
| Gavilyte-C | 22 | $368 | $17 |
| Mirtazapine | 11 | $337 | $31 |
| Furosemide | 37 | $206 | $6 |
| Metoclopramide | 31 | $144 | $5 |
| Amoxicillin | 15 | $130 | $9 |
| Metronidazole | 11 | $107 | $10 |
| Levofloxacin | 31 | $102 | $3 |
| Prednisone | 12 | $92 | $8 |
2021: 29 drugs
| Creon | 80 | $77,541 | $969 |
| Xifaxan | 14 | $37,508 | $2,679 |
| Linzess | 37 | $20,850 | $564 |
| Mesalamine | 21 | $11,306 | $538 |
| Mesalamine Er | 16 | $9,679 | $605 |
| Cholestyramine | 72 | $9,380 | $130 |
| Suprep | 86 | $9,215 | $107 |
| Pantoprazole | 424 | $8,098 | $19 |
| Dexilant | 11 | $8,045 | $731 |
| Omeprazole | 355 | $6,622 | $19 |
| Amitiza | 12 | $6,576 | $548 |
| Sucralfate | 13 | $3,205 | $247 |
| Lansoprazole | 64 | $2,876 | $45 |
| Lactulose | 34 | $2,145 | $63 |
| Famotidine | 47 | $1,250 | $27 |
| Rabeprazole | 15 | $1,027 | $68 |
| Constulose | 19 | $1,024 | $54 |
| Spironolactone | 54 | $885 | $16 |
| Cholestyramine Light | 11 | $752 | $68 |
| Peg 3350-Electrolyte | 27 | $601 | $22 |
| Dicyclomine | 17 | $517 | $30 |
| Propranolol | 15 | $443 | $30 |
| Furosemide | 47 | $199 | $4 |
| Gavilyte-C | 13 | $158 | $12 |
| Amitriptyline | 12 | $140 | $12 |
| Amoxicillin | 13 | $124 | $10 |
| Prednisone | 13 | $116 | $9 |
| Metoclopramide | 22 | $105 | $5 |
| Levofloxacin | 18 | $77 | $4 |
2020: 24 drugs
| Creon | 70 | $61,003 | $871 |
| Mesalamine Er | 17 | $11,966 | $704 |
| Ursodiol | 18 | $10,763 | $598 |
| Linzess | 18 | $10,658 | $592 |
| Suprep | 88 | $9,099 | $103 |
| Pantoprazole | 424 | $6,538 | $15 |
| Omeprazole | 371 | $5,874 | $16 |
| Cholestyramine | 51 | $5,374 | $105 |
| Lansoprazole | 68 | $2,551 | $38 |
| Esomeprazole Magnesium | 11 | $1,154 | $105 |
| Spironolactone | 53 | $1,065 | $20 |
| Lactulose | 28 | $1,014 | $36 |
| Famotidine | 44 | $974 | $22 |
| Gavilyte-C | 58 | $749 | $13 |
| Dicyclomine | 28 | $742 | $26 |
| Gavilyte-G | 48 | $669 | $14 |
| Sucralfate | 14 | $631 | $45 |
| Constulose | 14 | $572 | $41 |
| Diphenoxylate-Atropine | 14 | $369 | $26 |
| Propranolol | 17 | $278 | $16 |
| Furosemide | 53 | $196 | $4 |
| Metronidazole | 15 | $167 | $11 |
| Amoxicillin | 16 | $148 | $9 |
| Ciprofloxacin | 13 | $36 | $3 |
2019: 33 drugs
| Creon | 72 | $42,028 | $584 |
| Linzess | 32 | $17,722 | $554 |
| Apriso | 22 | $17,312 | $787 |
| Suprep | 138 | $13,666 | $99 |
| Ursodiol | 18 | $7,155 | $398 |
| Moviprep | 61 | $6,352 | $104 |
| Cholestyramine | 57 | $6,123 | $107 |
| Omeprazole | 293 | $6,064 | $21 |
| Pantoprazole | 381 | $5,999 | $16 |
| Tenofovir Disoproxil | 13 | $3,282 | $252 |
| Lactulose | 32 | $2,824 | $88 |
| Spironolactone | 70 | $2,339 | $33 |
| Lansoprazole | 37 | $1,765 | $48 |
| Rabeprazole | 11 | $1,245 | $113 |
| Sulfasalazine Dr | 11 | $1,239 | $113 |
| Constulose | 16 | $1,221 | $76 |
| Cholestyramine Light | 12 | $1,042 | $87 |
| Azathioprine | 13 | $878 | $68 |
| Gavilyte-C | 72 | $852 | $12 |
| Dicyclomine | 44 | $839 | $19 |
| Famotidine | 66 | $803 | $12 |
| Esomeprazole Magnesium | 16 | $577 | $36 |
| Ranitidine | 23 | $549 | $24 |
| Furosemide | 64 | $381 | $6 |
| Sucralfate | 13 | $338 | $26 |
| Peg 3350-Electrolyte | 35 | $328 | $9 |
| Polyethylene Glycol 3350 | 15 | $279 | $19 |
| Gavilyte-G | 16 | $214 | $13 |
| Amoxicillin | 16 | $196 | $12 |
| Metronidazole | 13 | $158 | $12 |
| Mirtazapine | 15 | $148 | $10 |
| Metoclopramide | 11 | $144 | $13 |
| Levofloxacin | 16 | $85 | $5 |
2018: 36 drugs
| Epclusa | 12 | $298,551 | $24,879 |
| Xifaxan | 16 | $45,013 | $2,813 |
| Creon | 55 | $30,411 | $553 |
| Linzess | 28 | $12,485 | $446 |
| Apriso | 16 | $11,829 | $739 |
| Dexilant | 25 | $11,701 | $468 |
| Moviprep | 89 | $8,863 | $100 |
| Carafate | 19 | $7,394 | $389 |
| Ursodiol | 25 | $6,225 | $249 |
| Suprep | 63 | $5,912 | $94 |
| Amitiza | 13 | $5,819 | $448 |
| Omeprazole | 259 | $5,480 | $21 |
| Pantoprazole | 309 | $5,029 | $16 |
| Cholestyramine | 38 | $4,619 | $122 |
| Polyethylene Glycol 3350 | 226 | $4,335 | $19 |
| Spironolactone | 54 | $1,674 | $31 |
| Sulfasalazine Dr | 15 | $1,123 | $75 |
| Lansoprazole | 15 | $822 | $55 |
| Famotidine | 83 | $816 | $10 |
| Sucralfate | 31 | $776 | $25 |
| Gavilyte-C | 65 | $764 | $12 |
| Clarithromycin | 13 | $672 | $52 |
| Azathioprine | 18 | $558 | $31 |
| Lactulose | 16 | $535 | $33 |
| Dicyclomine | 39 | $531 | $14 |
| Ranitidine | 29 | $528 | $18 |
| Diphenoxylate-Atropine | 11 | $468 | $43 |
| Esomeprazole Magnesium | 16 | $421 | $26 |
| Peg 3350-Electrolyte | 35 | $350 | $10 |
| Mirtazapine | 32 | $262 | $8 |
| Metronidazole | 15 | $249 | $17 |
| Furosemide | 43 | $243 | $6 |
| Amoxicillin | 21 | $228 | $11 |
| Metoclopramide | 20 | $138 | $7 |
| Ciprofloxacin | 13 | $90 | $7 |
| Levofloxacin | 12 | $81 | $7 |
2017: 34 drugs
| Harvoni | 15 | $491,795 | $32,786 |
| Xifaxan | 15 | $44,424 | $2,962 |
| Dexilant | 88 | $31,225 | $355 |
| Creon | 67 | $28,027 | $418 |
| Linzess | 50 | $21,679 | $434 |
| Ursodiol | 27 | $9,696 | $359 |
| Erythromycin Ethylsuccinate | 24 | $8,366 | $349 |
| Moviprep | 74 | $7,087 | $96 |
| Amitiza | 18 | $6,133 | $341 |
| Budesonide Ec | 18 | $6,087 | $338 |
| Suprep | 54 | $4,726 | $88 |
| Pantoprazole | 338 | $4,215 | $12 |
| Cholestyramine | 36 | $4,015 | $112 |
| Omeprazole | 285 | $3,764 | $13 |
| Carafate | 11 | $3,689 | $335 |
| Polyethylene Glycol 3350 | 211 | $3,568 | $17 |
| Sulfasalazine Dr | 19 | $1,395 | $73 |
| Spironolactone | 54 | $1,195 | $22 |
| Lactulose | 29 | $944 | $33 |
| Lansoprazole | 22 | $757 | $34 |
| Esomeprazole Magnesium | 13 | $746 | $57 |
| Constulose | 11 | $582 | $53 |
| Clarithromycin | 15 | $532 | $35 |
| Sucralfate | 23 | $426 | $19 |
| Ranitidine | 35 | $400 | $11 |
| Famotidine | 56 | $363 | $6 |
| Gavilyte-C | 27 | $342 | $13 |
| Peg 3350-Electrolyte | 26 | $266 | $10 |
| Furosemide | 49 | $249 | $5 |
| Dicyclomine | 27 | $242 | $9 |
| Peg-3350 and Electrolytes | 16 | $193 | $12 |
| Metronidazole | 16 | $175 | $11 |
| Mirtazapine | 28 | $160 | $6 |
| Amoxicillin | 13 | $73 | $6 |
2016: 30 drugs
| Harvoni | 18 | $574,935 | $31,941 |
| Dexilant | 91 | $28,461 | $313 |
| Xifaxan | 11 | $24,120 | $2,193 |
| Creon | 42 | $15,685 | $373 |
| Linzess | 26 | $10,403 | $400 |
| Eryped 200 | 16 | $8,757 | $547 |
| Apriso | 14 | $8,687 | $621 |
| Ursodiol | 11 | $7,984 | $726 |
| Moviprep | 71 | $6,357 | $90 |
| Omeprazole | 352 | $4,284 | $12 |
| Amitiza | 12 | $4,023 | $335 |
| Polyethylene Glycol 3350 | 165 | $3,921 | $24 |
| Pantoprazole | 276 | $3,406 | $12 |
| Carafate | 11 | $3,359 | $305 |
| Suprep | 40 | $3,328 | $83 |
| Nexium | 11 | $2,813 | $256 |
| Cholestyramine | 25 | $2,743 | $110 |
| Sulfasalazine Dr | 30 | $1,804 | $60 |
| Lansoprazole | 35 | $1,784 | $51 |
| Lactulose | 33 | $1,752 | $53 |
| Clarithromycin | 16 | $778 | $49 |
| Spironolactone | 50 | $762 | $15 |
| Ranitidine | 52 | $541 | $10 |
| Famotidine | 60 | $466 | $8 |
| Sucralfate | 15 | $387 | $26 |
| Dicyclomine | 26 | $262 | $10 |
| Furosemide | 38 | $232 | $6 |
| Mirtazapine | 20 | $118 | $6 |
| Amoxicillin | 14 | $110 | $8 |
| Ciprofloxacin | 13 | $72 | $6 |
2015: 25 drugs
| Harvoni | 17 | $542,791 | $31,929 |
| Dexilant | 74 | $18,420 | $249 |
| Linzess | 37 | $10,544 | $285 |
| Moviprep | 115 | $9,472 | $82 |
| Creon | 13 | $4,897 | $377 |
| Omeprazole | 327 | $4,786 | $15 |
| Nexium | 19 | $4,668 | $246 |
| Polyethylene Glycol 3350 | 135 | $3,670 | $27 |
| Ursodiol | 15 | $3,417 | $228 |
| Carafate | 13 | $3,317 | $255 |
| Mercaptopurine | 31 | $3,008 | $97 |
| Pantoprazole | 228 | $2,564 | $11 |
| Cholestyramine | 21 | $2,310 | $110 |
| Lansoprazole | 25 | $1,825 | $73 |
| Lactulose | 44 | $1,693 | $38 |
| Sulfasalazine Dr | 28 | $1,384 | $49 |
| Spironolactone | 56 | $1,145 | $20 |
| Clarithromycin | 18 | $689 | $38 |
| Dicyclomine | 52 | $445 | $9 |
| Azathioprine | 14 | $366 | $26 |
| Furosemide | 54 | $280 | $5 |
| Ranitidine | 20 | $176 | $9 |
| Peg 3350-Electrolyte | 13 | $135 | $10 |
| Amoxicillin | 17 | $129 | $8 |
| Famotidine | 23 | $107 | $5 |
2014: 19 drugs
| Asacol Hd | 18 | $13,001 | $722 |
| Nexium | 41 | $10,769 | $263 |
| Lialda | 15 | $8,341 | $556 |
| Moviprep | 98 | $7,847 | $80 |
| Dexilant | 34 | $6,666 | $196 |
| E.E.S. 200 | 14 | $5,036 | $360 |
| Amitiza | 15 | $4,563 | $304 |
| Omeprazole | 295 | $3,787 | $13 |
| Polyethylene Glycol 3350 | 96 | $2,697 | $28 |
| Pantoprazole | 118 | $1,087 | $9 |
| Spironolactone | 39 | $669 | $17 |
| Rabeprazole | 12 | $589 | $49 |
| Ranitidine | 11 | $416 | $38 |
| Furosemide | 45 | $178 | $4 |
| Peg 3350-Electrolyte | 11 | $118 | $11 |
| Famotidine | 19 | $113 | $6 |
| Amitriptyline | 20 | $96 | $5 |
| Dicyclomine | 11 | $86 | $8 |
| Ciprofloxacin | 14 | $57 | $4 |
2013: 7 drugs
| Nexium | 14 | $3,917 | $280 |
| Moviprep | 25 | $1,844 | $74 |
| Polyethylene Glycol 3350 | 28 | $807 | $29 |
| Omeprazole | 63 | $801 | $13 |
| Spironolactone | 19 | $588 | $31 |
| Pantoprazole | 11 | $121 | $11 |
| Furosemide | 16 | $58 | $4 |
Money from drug and device companies
$1,694 in 2025
| 2025 | 10 | 68 | None | $1,694 |
| 2024 | 10 | 43 | None | $1,329 |
| 2023 | 8 | 12 | None | $417 |
| 2022 | 3 | 3 | None | $112 |
| 2021 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $583 | 25 payments
|
| Phathom Pharmaceuticals | Voquezna | $302 | 6 payments
|
| Ardelyx | Ibsrela | $193 | 7 payments
|
| Genzyme | Dupixent | $181 | 6 payments
|
| Janssen Biotech | Tremfya | $165 | 9 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $144 | 10 payments
|
See all 68 published payments
| Novo Nordisk | Meals · 2025-12-19 | Wegovy | $16 |
| Ardelyx | Meals · 2025-12-17 | Ibsrela | $22 |
| Madrigal Pharmaceuticals | Meals · 2025-12-17 | Rezdiffra | $8 |
| Abbvie | Meals · 2025-12-16 | Rinvoq | $21 |
| Phathom Pharmaceuticals | Meals · 2025-12-04 | Voquezna | $31 |
| Abbvie | Meals · 2025-12-02 | Rinvoq | $21 |
| Novo Nordisk | Meals · 2025-12-01 | Wegovy | $20 |
| AstraZeneca Pharmaceuticals LP | Education · 2025-11-25 | Enhertu | $43 |
| Ardelyx | Meals · 2025-11-24 | Ibsrela | $13 |
| Abbvie | Meals · 2025-11-20 | Rinvoq | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-11-20 | Rezdiffra | $8 |
| Madrigal Pharmaceuticals | Meals · 2025-11-20 | Rezdiffra | $6 |
| Genzyme | Meals · 2025-11-13 | Dupixent | $30 |
| Abbvie | Meals · 2025-11-10 | Rinvoq | $19 |
| Janssen Biotech | Meals · 2025-11-06 | Tremfya | $24 |
| Abbvie | Meals · 2025-11-04 | Skyrizi | $15 |
| Phathom Pharmaceuticals | Meals · 2025-10-20 | Voquezna | $32 |
| Janssen Biotech | Meals · 2025-10-16 | Tremfya | $27 |
| Abbvie | Meals · 2025-10-14 | Rinvoq | $33 |
| Abbvie | Meals · 2025-10-10 | Rinvoq | $17 |
| Genzyme | Meals · 2025-10-03 | Dupixent | $30 |
| Abbvie | Meals · 2025-09-19 | Linzess | $6 |
| Janssen Biotech | Meals · 2025-09-12 | Tremfya | $10 |
| Ardelyx | Meals · 2025-09-11 | Ibsrela | $33 |
| Abbvie | Meals · 2025-08-14 | Rinvoq | $14 |
| Genzyme | Meals · 2025-08-06 | Dupixent | $30 |
| Abbvie | Meals · 2025-07-31 | Skyrizi | $34 |
| Abbvie | Meals · 2025-07-30 | Rinvoq | $11 |
| Ardelyx | Meals · 2025-07-30 | Ibsrela | $32 |
| Phathom Pharmaceuticals | Meals · 2025-07-15 | Voquezna | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-07-15 | Rezdiffra | $7 |
| Abbvie | Meals · 2025-07-11 | Rinvoq | $27 |
| Genzyme | Meals · 2025-07-10 | Dupixent | $33 |
| Celltrion USA | Meals · 2025-07-09 | Vegzelma | $22 |
| Janssen Biotech | Meals · 2025-07-08 | Tremfya | $7 |
| Abbvie | Meals · 2025-06-26 | Linzess | $13 |
| Madrigal Pharmaceuticals | Meals · 2025-06-26 | Rezdiffra | $27 |
| Janssen Biotech | Meals · 2025-06-18 | Tremfya | $17 |
| Abbvie | Meals · 2025-06-13 | Rinvoq | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-06-03 | Rezdiffra | $9 |
| Abbvie | Meals · 2025-05-30 | Rinvoq | $17 |
| Abbvie | Meals · 2025-05-27 | Linzess | $10 |
| Abbvie | Meals · 2025-05-27 | Linzess | $20 |
| Abbvie | Meals · 2025-05-15 | Skyrizi | $106 |
| Abbvie | Meals · 2025-05-08 | Skyrizi | $5 |
| Janssen Biotech | Meals · 2025-05-05 | Tremfya | $20 |
| Genzyme | Meals · 2025-05-02 | Dupixent | $27 |
| Madrigal Pharmaceuticals | Meals · 2025-04-29 | Rezdiffra | $26 |
| Phathom Pharmaceuticals | Meals · 2025-04-24 | Voquezna | $30 |
| Abbvie | Meals · 2025-04-18 | Rinvoq | $25 |
| Janssen Biotech | Meals · 2025-04-15 | Tremfya | $12 |
| Madrigal Pharmaceuticals | Meals · 2025-04-10 | Rezdiffra | $23 |
| Madrigal Pharmaceuticals | Meals · 2025-04-10 | Rezdiffra | $3 |
| Abbvie | Meals · 2025-03-28 | Skyrizi | $21 |
| Janssen Biotech | Meals · 2025-03-26 | Tremfya | $14 |
| Abbvie | Meals · 2025-03-18 | Linzess | $27 |
| Phathom Pharmaceuticals | Meals · 2025-03-18 | Voquezna | $148 |
| Abbvie | Meals · 2025-03-14 | Rinvoq | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-03-13 | Rezdiffra | $26 |
| Janssen Biotech | Meals · 2025-03-12 | Tremfya | $33 |
| Abbvie | Meals · 2025-03-11 | Rinvoq | $19 |
| Genzyme | Meals · 2025-03-06 | Dupixent | $31 |
| Phathom Pharmaceuticals | Meals · 2025-02-25 | Voquezna | $32 |
| Ardelyx | Meals · 2025-02-14 | Ibsrela | $33 |
| Ardelyx | Meals · 2025-02-03 | Ibsrela | $30 |
| Ardelyx | Meals · 2025-01-31 | Ibsrela | $31 |
| Abbvie | Meals · 2025-01-16 | Rinvoq | $29 |
| Braintree Laboratories | Meals · 2025-01-09 | Suflave | $24 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,329
| Abbvie | Skyrizi | $455 | 18 payments
|
| Genzyme | Dupixent | $201 | 8 payments
|
| Phathom Pharmaceuticals | Voquezna | $164 | 2 payments
|
| Ipsen Biopharmaceuticals | Iqirvo | $150 | 1 payment
|
| Ardelyx | Ibsrela | $120 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Eohilia | $87 | 3 payments
|
| Celltrion USA | Zymfentra | $63 | 2 payments
|
| Janssen Biotech | Stelara | $38 | 2 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $32 | 2 payments
|
| Endogastric Solutions | Esophyx | $19 | 1 payment
|
2023: $417
| Regeneron Healthcare Solutions | Dupixent | $125 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Gattex | $59 | 2 payments
|
| AbbVie | Rinvoq | $57 | 2 payments
|
| Genzyme | Dupixent | $45 | 2 payments
|
| Celgene | Zeposia | $40 | 2 payments
|
| Celltrion USA | Zymfentra | $37 | 1 payment
|
| Ferring Pharmaceuticals | Rebyota | $28 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $25 | 1 payment
|
2022: $112
| Salix Pharmaceuticals a division of Bausch Health US | Trulance | $75 | 1 payment
|
| Janssen Biotech | Remicade | $19 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $19 | 1 payment
|
2021: $23
| Boston Scientific | Exalt | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134311236
- Licence
- CA A97611California A97611: Current · expires 2028-06-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 12291 Washington Blvd, Suite 201, Whittier, CA, 90606
- NPI first listed
- 2007-08-13
- NPI last updated
- 2014-08-22
This is when the NPI record was last certified, not a medical board exam.